NCT03854136

Brief Summary

Patients being treated for musculoskeletal tumors were included in the study. Their records were reviewed retrospectively and data was gathered regarding types of surgeries and post-operative complications including recurrence or development of secondary tumors if any.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 1995

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 1995

Completed
23.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

February 23, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 26, 2019

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

23.6 years

First QC Date

February 23, 2019

Last Update Submit

February 23, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recurrence

    Recurrence of tumor at primary site

    5 years

Interventions

Wide margin excision of tumors +/- limb preservation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of all ages and gender who underwent surgical intervention for musculoskeletal tumors at our institution were included

You may qualify if:

  • Patients undergoing treatment for musculoskeletal tumors

You may not qualify if:

  • Patients who did not undergo any surgical intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan University Hospital

Karachi, Sindh, Pakistan

RECRUITING

MeSH Terms

Conditions

Musculoskeletal Diseases

Study Officials

  • Obada Hassan, FCPS

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Volunteer

Study Record Dates

First Submitted

February 23, 2019

First Posted

February 26, 2019

Study Start

July 1, 1995

Primary Completion

February 1, 2019

Study Completion

March 1, 2019

Last Updated

February 26, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations